Orexigen Therapeutics (OREX) 8.01 $OREX Most ac
Post# of 64074
Posted On: 03/05/2015 10:06:23 PM
Orexigen Therapeutics (OREX) 8.01 $OREX
Most active Nasdaq-traded stocks
AP - Thu Mar 05, 5:04PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
MU: 29.28 (+0.02), PCYC: 254.22 (+23.74), FB: 81.21 (+0.32), INTC: 33.73 (-0.39), OREX: 8.01 (-0.48), FOX: 34.03 (-0.04), GERN: 3.78 (+0.97), FOXA: 34.87 (-0.10), MSFT: 43.11 (+0.05), ZNGA: 2.41 (+0.02), AAPL: 126.41 (-2.13), CSCO: 29.30 (-0.03)
Nasdaq stocks posting largest percentage increases
AP - Thu Mar 05, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
GLNG: 34.35 (+4.84), HYGS: 14.78 (+1.02), OREX: 8.01 (-0.48), ECYT: 6.25 (-0.48), GLMD: 9.62 (+1.03), FCSC: 5.94 (+0.29), KYTH: 50.00 (+10.10), HYG.TO: 18.50 (+1.45), ATRA: 28.75 (+2.20), PEIX: 11.75 (+2.42), CECO: 6.00 (unch)
Orexigen Soars as Interim Data on Contrave Comes to Light - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 3:45PM CST
Orexigen Therapeutics (OREX) revealed that interim analysis from a cardiovascular study showed patients when treated with Contrave (59%) resulted in a statistically significant reduction in major adverse cardiac events as compared to placebo (35%).
OREX: 8.01 (-0.48), HZNP: 20.84 (-0.33), THRX: 19.86 (+0.22)
Orexigen Therapeutics (OREX) Stock Surging Today on Heavy Volume
at The Street - Wed Mar 04, 2:05PM CST
Orexigen Therapeutics (OREX) stock is up this afternoon to continue gains from yesterday's trading session.
OREX: 8.01 (-0.48)
Orexigen's Cardiovascular Safety Data Is A Breakthrough
Aristides Capital - at Seeking Alpha - Wed Mar 04, 11:57AM CST
OREX: 8.01 (-0.48)
Why Shares of Orexigen Therapeutics, Inc. Bolted Higher
George Budwell, The Motley Fool - Motley Fool - Wed Mar 04, 10:54AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What : Orexigen Therapeutics' shares continued their...
OREX: 8.01 (-0.48)
Biotech Stock Roundup: Orexigen Soars on Contrave Data, Amgen Scores in Study - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Mar 04, 10:35AM CST
Orexigen (OREX) soars on news regrading obesity drug, Contrave. Amgen's (AMGN) multiple myeloma drug, Kyprolis, is better than Velcade in a head-to-head study.
OREX: 8.01 (-0.48), VRTX: 126.96 (+6.91), ISIS: 71.76 (+1.60), GILD: 103.42 (+0.36), AMGN: 159.60 (+0.41), ARNA: 4.23 (-0.09), CELG: 120.71 (+1.14)
Premarket Gainers / Losers as of 9:10 em
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 8:13AM CST
BV: 6.26 (-0.15), AMRN: 1.67 (-0.02), PHMD: 1.85 (-0.13), BOBE: 47.76 (+1.40), NVGN: 2.98 (-0.38), EFUT: 4.40 (-0.30), TNET: 33.51 (-0.42), ATOS: 2.01 (-0.02), FAST: 40.62 (+0.80), W: 27.78 (-1.12), TIVO: 11.12 (-0.44), CYCC: 1.06 (-0.04), ANF: 20.21 (-0.06), CYTX: 1.16 (+0.02), AEO: 16.34 (+0.38), AMBA: 64.39 (-3.10), CRMD: 7.76 (+1.60), ONCY: 1.05 (+0.04), EXAS: 22.43 (+0.53), ATHM: 46.83 (+4.22), SOL: 1.63 (+0.20), VEEV: 24.73 (-0.99), OREX: 8.01 (-0.48), NURO: 1.75 (-0.04), ACHN: 10.99 (-0.64), CNDO: 3.37 (+0.14), SWHC: 14.40 (+0.06), IFON: 2.52 (-0.19)
Orexigen Soars: Good News Is Heart Data, Bad News Is Data May Be Compromised
Spencer Osborne - at Seeking Alpha - Wed Mar 04, 8:01AM CST
OREX: 8.01 (-0.48), VVUS: 2.87 (-0.11), ARNA: 4.23 (-0.09)
Arena's Post Earnings Sell-Off Offers A Good Opportunity To Buy
Kanak Kanti De - at Seeking Alpha - Wed Mar 04, 7:46AM CST
OREX: 8.01 (-0.48), ARNA: 4.23 (-0.09)
Cardiovascular Safety Surprise: Wait, Then Buy Orexigen
Rx Stocks - at Seeking Alpha - Wed Mar 04, 7:18AM CST
OREX: 8.01 (-0.48), VVUS: 2.87 (-0.11), ARNA: 4.23 (-0.09)
Contrave may help heart
at Investor's Business Daily - Tue Mar 03, 5:29PM CST
Shares of Orexigen (OREX) jumped 32% to 7.64, a 4-year high, in enormous volume after the biotech reported late Mon. that its obesity drug Contrave may reduce cardiovascular events such as heart attacks and strokes. Interim analysis of an ongoing...
OREX: 8.01 (-0.48)
Nasdaq stocks posting largest volume increases
AP - Tue Mar 03, 5:06PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
OREX: 8.01 (-0.48), GDEF: 10.36 (-0.02), WBB: 17.29 (+0.07), ONCY: 1.05 (+0.04), CYCC: 1.06 (-0.04), DRAM: 2.77 (-0.52), AXPW: 0.19 (-0.04), CMLS: 3.03 (-0.10), SQBK: 25.50 (-0.24), MITL: 9.70 (+0.14), TSRI: 4.87 (-0.20), MBLX: 0.86 (-0.11)
Arena says Belviq refiling in Europe should occur by Q1 2016
Seeking Alpha - at Seeking Alpha - Tue Mar 03, 3:55PM CST
OREX: 8.01 (-0.48), VVUS: 2.87 (-0.11), ARNA: 4.23 (-0.09)
Best Buy and Orexigen are big market movers
AP - Tue Mar 03, 3:44PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
OREX: 8.01 (-0.48), ENDP: 87.71 (+2.06), SONC: 33.51 (-0.21), NTRI: 18.88 (+0.15), CMLS: 3.03 (-0.10), CZR: 10.16 (-0.20), FSL: 40.09 (-0.27), PCRX: 98.40 (+3.01), OMER: 26.35 (+0.15)
Orexigen's Contrave data release may have not have been a good idea
Seeking Alpha - at Seeking Alpha - Tue Mar 03, 2:42PM CST
OREX: 8.01 (-0.48)
Most active Nasdaq-traded stocks
AP - Thu Mar 05, 5:04PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
MU: 29.28 (+0.02), PCYC: 254.22 (+23.74), FB: 81.21 (+0.32), INTC: 33.73 (-0.39), OREX: 8.01 (-0.48), FOX: 34.03 (-0.04), GERN: 3.78 (+0.97), FOXA: 34.87 (-0.10), MSFT: 43.11 (+0.05), ZNGA: 2.41 (+0.02), AAPL: 126.41 (-2.13), CSCO: 29.30 (-0.03)
Nasdaq stocks posting largest percentage increases
AP - Thu Mar 05, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
GLNG: 34.35 (+4.84), HYGS: 14.78 (+1.02), OREX: 8.01 (-0.48), ECYT: 6.25 (-0.48), GLMD: 9.62 (+1.03), FCSC: 5.94 (+0.29), KYTH: 50.00 (+10.10), HYG.TO: 18.50 (+1.45), ATRA: 28.75 (+2.20), PEIX: 11.75 (+2.42), CECO: 6.00 (unch)
Orexigen Soars as Interim Data on Contrave Comes to Light - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 3:45PM CST
Orexigen Therapeutics (OREX) revealed that interim analysis from a cardiovascular study showed patients when treated with Contrave (59%) resulted in a statistically significant reduction in major adverse cardiac events as compared to placebo (35%).
OREX: 8.01 (-0.48), HZNP: 20.84 (-0.33), THRX: 19.86 (+0.22)
Orexigen Therapeutics (OREX) Stock Surging Today on Heavy Volume
at The Street - Wed Mar 04, 2:05PM CST
Orexigen Therapeutics (OREX) stock is up this afternoon to continue gains from yesterday's trading session.
OREX: 8.01 (-0.48)
Orexigen's Cardiovascular Safety Data Is A Breakthrough
Aristides Capital - at Seeking Alpha - Wed Mar 04, 11:57AM CST
OREX: 8.01 (-0.48)
Why Shares of Orexigen Therapeutics, Inc. Bolted Higher
George Budwell, The Motley Fool - Motley Fool - Wed Mar 04, 10:54AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What : Orexigen Therapeutics' shares continued their...
OREX: 8.01 (-0.48)
Biotech Stock Roundup: Orexigen Soars on Contrave Data, Amgen Scores in Study - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Mar 04, 10:35AM CST
Orexigen (OREX) soars on news regrading obesity drug, Contrave. Amgen's (AMGN) multiple myeloma drug, Kyprolis, is better than Velcade in a head-to-head study.
OREX: 8.01 (-0.48), VRTX: 126.96 (+6.91), ISIS: 71.76 (+1.60), GILD: 103.42 (+0.36), AMGN: 159.60 (+0.41), ARNA: 4.23 (-0.09), CELG: 120.71 (+1.14)
Premarket Gainers / Losers as of 9:10 em
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 8:13AM CST
BV: 6.26 (-0.15), AMRN: 1.67 (-0.02), PHMD: 1.85 (-0.13), BOBE: 47.76 (+1.40), NVGN: 2.98 (-0.38), EFUT: 4.40 (-0.30), TNET: 33.51 (-0.42), ATOS: 2.01 (-0.02), FAST: 40.62 (+0.80), W: 27.78 (-1.12), TIVO: 11.12 (-0.44), CYCC: 1.06 (-0.04), ANF: 20.21 (-0.06), CYTX: 1.16 (+0.02), AEO: 16.34 (+0.38), AMBA: 64.39 (-3.10), CRMD: 7.76 (+1.60), ONCY: 1.05 (+0.04), EXAS: 22.43 (+0.53), ATHM: 46.83 (+4.22), SOL: 1.63 (+0.20), VEEV: 24.73 (-0.99), OREX: 8.01 (-0.48), NURO: 1.75 (-0.04), ACHN: 10.99 (-0.64), CNDO: 3.37 (+0.14), SWHC: 14.40 (+0.06), IFON: 2.52 (-0.19)
Orexigen Soars: Good News Is Heart Data, Bad News Is Data May Be Compromised
Spencer Osborne - at Seeking Alpha - Wed Mar 04, 8:01AM CST
OREX: 8.01 (-0.48), VVUS: 2.87 (-0.11), ARNA: 4.23 (-0.09)
Arena's Post Earnings Sell-Off Offers A Good Opportunity To Buy
Kanak Kanti De - at Seeking Alpha - Wed Mar 04, 7:46AM CST
OREX: 8.01 (-0.48), ARNA: 4.23 (-0.09)
Cardiovascular Safety Surprise: Wait, Then Buy Orexigen
Rx Stocks - at Seeking Alpha - Wed Mar 04, 7:18AM CST
OREX: 8.01 (-0.48), VVUS: 2.87 (-0.11), ARNA: 4.23 (-0.09)
Contrave may help heart
at Investor's Business Daily - Tue Mar 03, 5:29PM CST
Shares of Orexigen (OREX) jumped 32% to 7.64, a 4-year high, in enormous volume after the biotech reported late Mon. that its obesity drug Contrave may reduce cardiovascular events such as heart attacks and strokes. Interim analysis of an ongoing...
OREX: 8.01 (-0.48)
Nasdaq stocks posting largest volume increases
AP - Tue Mar 03, 5:06PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
OREX: 8.01 (-0.48), GDEF: 10.36 (-0.02), WBB: 17.29 (+0.07), ONCY: 1.05 (+0.04), CYCC: 1.06 (-0.04), DRAM: 2.77 (-0.52), AXPW: 0.19 (-0.04), CMLS: 3.03 (-0.10), SQBK: 25.50 (-0.24), MITL: 9.70 (+0.14), TSRI: 4.87 (-0.20), MBLX: 0.86 (-0.11)
Arena says Belviq refiling in Europe should occur by Q1 2016
Seeking Alpha - at Seeking Alpha - Tue Mar 03, 3:55PM CST
OREX: 8.01 (-0.48), VVUS: 2.87 (-0.11), ARNA: 4.23 (-0.09)
Best Buy and Orexigen are big market movers
AP - Tue Mar 03, 3:44PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:
OREX: 8.01 (-0.48), ENDP: 87.71 (+2.06), SONC: 33.51 (-0.21), NTRI: 18.88 (+0.15), CMLS: 3.03 (-0.10), CZR: 10.16 (-0.20), FSL: 40.09 (-0.27), PCRX: 98.40 (+3.01), OMER: 26.35 (+0.15)
Orexigen's Contrave data release may have not have been a good idea
Seeking Alpha - at Seeking Alpha - Tue Mar 03, 2:42PM CST
OREX: 8.01 (-0.48)
(0)
(0)Scroll down for more posts ▼